Debt to Capital Ratio: A measurement of a company's financial leverage, calculated as the company's long-term debt divided by its total capital. Calculated as: Total Long-Term Debt / (Total Long-Term Debt + Shareholders Equity)
Sagimet Biosciences Inc. (SGMT) Debt to Capital Ratio data is not available.
| Income Statement Financials | |
-- |
|
$-13.95M |
|
-- |
|
-- |
|
$15.82M |
|
$-15.82M |
|
$1.86M |
|
$-13.95M |
|
$-13.95M |
|
$-13.95M |
|
$-13.95M |
|
$-13.95M |
|
$-13.95M |
|
$-15.82M |
|
$-15.84M |
|
53.11M |
|
53.11M |
|
$-0.26 |
|
$-0.26 |
|
| Balance Sheet Financials | |
$243.99M |
|
-- |
|
$19.44M |
|
$263.43M |
|
$5.42M |
|
-- |
|
$1.86M |
|
$7.28M |
|
$256.15M |
|
$256.15M |
|
$256.15M |
|
61.78M |
|
| Cash Flow Statement Financials | |
$-19.71M |
|
$-13.80M |
|
$164.39M |
|
$35.02M |
|
$165.90M |
|
$130.88M |
|
$5.53M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
45.02 |
|
-- |
|
-- |
|
|
Debt to Capital Ratio |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.71M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-5.45% |
|
-5.45% |
|
-5.30% |
|
-5.45% |
|
$4.15 |
|
$-0.37 |
|
$-0.37 |
|